Diagnosis of Epidermolysis Bullosa Acquisita: Multicentre Comparison of Different Assays for Serum Anti-type VII Collagen Reactivity
DOI:
https://doi.org/10.2340/00015555-3774Keywords:
epidermolysis bullosa acquisita, autoantibody, type VII collagen, BIOCHIP, enzyme-linked immunoassay, immunoblotAbstract
Epidermolysis bullosa acquisita is a pemphigoid disease characterized by autoantibodies against type VII collagen. This study compared the sensitivity and specificity of 6 diagnostic assays: type VII collagen non-collagenous domains enzyme-linked immunoassay (NC1/2 ELISA) (MBL, Nagoya, Japan); type VII collagen NC1 ELISA (Euroimmun, Lübeck, Germany); indirect immunofluorescence (IF) microscopy test based on the expression of recombinant NC1 in a human cell line (NC1 BIOCHIP®; Euroimmun); full-length recombinant type VII collagen ELISA; immunoblotting with full-length type VII collagen in the extract of human dermis; and immunoblotting with recombinant NC1. Immunoblotting with recombinant NC1 showed a sensitivity of 93.1% and specificity of 100%, followed by NC1 BIOCHIP® (sensitivity, 89.1%; specificity, 100%), immunoblotting with human dermis (sensitivity, 87.1%; specificity 100%), NC1-ELISA (sensitivity 82.2%; specificity 98.6%), NC1/NC2 ELISA (sensitivity 88.1%; specificity 93.3%), and full-length type VII collagen ELISA (sensitivity 80.2%; specificity 93.8%).
Downloads
References
Hubner F, Recke A, Zillikens D, Linder R, Schmidt E. Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany. J Invest Dermatol 2016; 136: 2495-2498.
DOI: https://doi.org/10.1016/j.jid.2016.07.013
Woodley DT, Briggaman RA, O'Keefe EJ, Inman AO, Queen LL, Gammon WR. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 1984; 310: 1007-1013.
DOI: https://doi.org/10.1056/NEJM198404193101602
Goletz S, Zillikens D, Schmidt E. Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases. Exp Dermatol 2017; 26: 1154-1162.
DOI: https://doi.org/10.1111/exd.13446
Woodley DT, Burgeson RE, Lunstrum G, Bruckner-Tuderman L, Reese M, Briggaman RA. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 1988; 81: 683-687.
DOI: https://doi.org/10.1172/JCI113373
Kasperkiewicz M, Sadik CD, Bieber K, Ibrahim SM, Manz RA, Schmidt E, et al. Epidermolysis bullosa acquisita: from pathophysiology to novel therapeutic options. J Invest Dermatol 2016; 136: 24-33.
DOI: https://doi.org/10.1038/JID.2015.356
Koga H, Prost-Squarcioni C, Iwata H, Jonkman MF, Ludwig RJ, Bieber K. Epidermolysis bullosa acquisita: the 2019 Update. Front Med (Lausanne) 2018; 5: 362.
DOI: https://doi.org/10.3389/fmed.2018.00362
Vorobyev A, Ludwig RJ, Schmidt E. Clinical features and diagnosis of epidermolysis bullosa acquisita. Expert Rev Clin Immunol 2017; 13: 157-169.
DOI: https://doi.org/10.1080/1744666X.2016.1221343
Schmidt E, Groves R. Immunobullous diseases. In: Griffith C, Barker J, Chalmers, Bleiker T, Creamer D, editors. Rook's textbook of dermatology, part 3, chapter 50, 9th edition. Chichester: Wiley-Blackwell, 2016; 50: p. 1-56.
Prost-Squarcioni C, Caux F, Schmidt E, Jonkman MF, Vassileva S, Kim SC, et al. International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita. Br J Dermatol 2018; 179: 30-41.
DOI: https://doi.org/10.1111/bjd.16138
Vodegel RM, Jonkman MF, Pas HH, de Jong MC. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol 2004; 151: 112-118.
DOI: https://doi.org/10.1111/j.1365-2133.2004.06006.x
Meijer JM, Atefi I, Diercks GFH, Vorobyev A, Zuiderveen J, Meijer HJ, et al. Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases. J Am Acad Dermatol 2018; 78: 754-759e6.
DOI: https://doi.org/10.1016/j.jaad.2017.11.029
Terra JB, Meijer JM, Jonkman MF, Diercks GF. The n- vs. u-serration is a learnable criterion to differentiate pemphigoid from epidermolysis bullosa acquisita in direct immunofluorescence serration pattern analysis. Br J Dermatol 2013; 169: 100-105.
DOI: https://doi.org/10.1111/bjd.12308
Lau I, Goletz S, Holtsche MM, Zillikens D, Fechner K, Schmidt E. Anti-p200 pemphigoid is the most common pemphigoid disease with serum antibodies against the dermal side by indirect immunofluorescence microscopy on human salt-split skin. J Am Acad Dermatol 2019; 81: 1195-1197.
DOI: https://doi.org/10.1016/j.jaad.2019.03.077
Lapiere JC, Woodley DT, Parente MG, Iwasaki T, Wynn KC, Christiano AM, et al. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 1993; 92: 1831-1839.
DOI: https://doi.org/10.1172/JCI116774
Saleh MA, Ishii K, Kim YJ, Murakami A, Ishii N, Hashimoto T, et al. Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients. J Dermatol Sci 2011; 62: 169-175.
DOI: https://doi.org/10.1016/j.jdermsci.2011.03.003
Ishii N, Yoshida M, Hisamatsu Y, Ishida-Yamamoto A, Nakane H, Iizuka H, et al. Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. Br J Dermatol 2004; 150: 843-851.
DOI: https://doi.org/10.1111/j.1365-2133.2004.05933.x
Komorowski L, Muller R, Vorobyev A, Probst C, Recke A, Jonkman MF, et al. Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita. J Am Acad Dermatol 2013; 68: e89-e95.
DOI: https://doi.org/10.1016/j.jaad.2011.12.032
Feliciani C, Caldarola G, Kneisel A, Podstawa E, Pfutze M, Pfutzner W, et al. IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses. Br J Dermatol 2009; 161: 306-312.
DOI: https://doi.org/10.1111/j.1365-2133.2009.09266.x
Schmidt E, Sticherling M, Sardy M, Eming R, Goebeler M, Hertl M, et al. S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update. J Dtsch Dermatol Ges 2020; 18: 516-526.
DOI: https://doi.org/10.1111/ddg.14097
Joly P, Horwath B, Patsatsi A, Uzun S, Bech R, Beissert S, et al. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol 2020; 34: 1900-1913.
DOI: https://doi.org/10.1111/jdv.16752
Goletz S, Hashimoto T, Zillikens D, Schmidt E. Anti-p200 pemphigoid. J Am Acad Dermatol 2014; 71: 185-191.
DOI: https://doi.org/10.1016/j.jaad.2014.02.036
Goletz S, Probst C, Komorowski L, Schlumberger W, Fechner K, van Beek N, et al. A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid. Br J Dermatol 2019; 180: 149-156.
DOI: https://doi.org/10.1111/bjd.17202
Mecklenbeck S, Compton SH, Mejia JE, Cervini R, Hovnanian A, Bruckner-Tuderman L, et al. A microinjected COL7A1-PAC vector restores synthesis of intact procollagen VII in a dystrophic epidermolysis bullosa keratinocyte cell line. Hum Gene Ther 2002; 13: 1655-1662.
DOI: https://doi.org/10.1089/10430340260201743
Titeux M, Pendaries V, Zanta-Boussif MA, Decha A, Pironon N, Tonasso L, et al. SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa. Mol Ther 2010; 18: 1509-1518.
DOI: https://doi.org/10.1038/mt.2010.91
Chen M, Costa FK, Lindvay CR, Han YP, Woodley DT, The recombinant expression of full-length type VII collagen and characterization of molecular mechanisms underlying dystrophic epidermolysis bullosa. J Biol Chem 2002; 277: 2118-2124.
DOI: https://doi.org/10.1074/jbc.M108779200
Pendaries V, Gasc G, Titeux M, Leroux C, Vitezica ZG, Mejia JE, et al. Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa. Gene Ther 2010; 17: 930-937.
DOI: https://doi.org/10.1038/gt.2010.36
Seta V, Aucouturier F, Bonnefoy J, Le Roux-Villet C, Pendaries V, Alexandre M, et al. Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA). J Am Acad Dermatol 2016; 74: 1166-1172.
DOI: https://doi.org/10.1016/j.jaad.2016.01.005
Zillikens D, Kawahara Y, Ishiko A, Shimizu H, Mayer J, Rank C V et al. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 1996; 106: 1333-1338.
DOI: https://doi.org/10.1111/1523-1747.ep12349283
Groth S, Recke A, Vafia K, Ludwig RJ, Hashimoto T, Zillikens D, et al. Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid. Br J Dermatol 2011; 164: 76-82.
DOI: https://doi.org/10.1111/j.1365-2133.2010.10056.x
Iwata H, Vorobyev A, Koga H, Recke A, Zillikens D, Prost-Squarcioni C, et al. Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients. Orphanet J Rare Dis 2018; 13: 153.
DOI: https://doi.org/10.1186/s13023-018-0896-1
Kridin K, Kneiber D, Kowalski EH, Valdebran M, Amber KT. Epidermolysis bullosa acquisita: a comprehensive review. Autoimmun Rev 2019; 18: 786-795.
DOI: https://doi.org/10.1016/j.autrev.2019.06.007
Prost C, Dubertret L, Fosse M, Wechsler J, Touraine R. A routine immuno-electron microscopic technique for localizing an auto-antibody on epidermal basement membrane. Br J Dermatol 1984; 110: 1-7.
DOI: https://doi.org/10.1111/j.1365-2133.1984.tb07305.x
Marzano A V, Cozzani E, Biasin M, Russo I, and Alaibac M, The use of Biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita. Arch Dermatol Res 2016; 308: 273-276.
DOI: https://doi.org/10.1007/s00403-016-1632-0
Calabresi V, Sinistro A, Cozzani E, Cerasaro C, Lolicato F, Muscianese M, et al. Sensitivity of different assays for the serological diagnosis of epidermolysis bullosa acquisita: analysis of a cohort of 24 Italian patients. J Eur Acad Dermatol Venereol 2014; 28: 483-490.
DOI: https://doi.org/10.1111/jdv.12129
Horvath O N, Varga R, Kaneda M, Schmidt E, Ruzicka T, Sardy M. Diagnostic performance of the "MESACUP anti-Skin profile TEST". Eur J Dermatol 2016; 26: 56-63.
DOI: https://doi.org/10.1684/ejd.2015.2692
Kim JH, Kim YH, Kim S, Noh EB, Kim SE, Vorobyev A, et al. Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions. J Eur Acad Dermatol Venereol 2012; 27: e224-e230.
DOI: https://doi.org/10.1111/j.1468-3083.2012.04617.x
Schmidt T, Hoch M, Lotfi Jad SS, Solimani F, Di Zenzo G, Marzano AV, et al. Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis. Br J Dermatol 2017; 177: 1683-1692.
DOI: https://doi.org/10.1111/bjd.15800
Holtsche MM, Goletz S, von Georg A, van Beek N, Hubner F, Pigors M, et al. Serological characterization of anti-p200 pemphigoid: epitope spreading as a common phenomenon. J Am Acad Dermatol 2021; 84: 1155-1157.
DOI: https://doi.org/10.1016/j.jaad.2020.07.076
Hashimoto T, Jin Z, Ishii N. Clinical and immunological studies for 105 Japanese seropositive patients of epidermolysis bullosa acquisita examined at Kurume University. Expert Rev Clin Immunol 2016; 12: 895-902.
DOI: https://doi.org/10.1080/1744666X.2016.1196136
Jonkman MF, Meijer JM, Diercks GFH, Pas HH. Response to 'Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis'. Br J Dermatol 2018; 178: 573.
DOI: https://doi.org/10.1111/bjd.16023
Terra JB, Jonkman MF, Diercks GF, and Pas HH. Low sensitivity of type VII collagen enzyme-linked immunosorbent assay in epidermolysis bullosa acquisita: serration pattern analysis on skin biopsy is required for diagnosis. Br J Dermatol 2013; 169: 164-167.
Published
How to Cite
License
Copyright (c) 2021 Maike M. Holtsche, Nina van Beek, Takashi Hashimoto, Giovanni Di Zenzo, Detlef Zillikens, Catherine Prost-Squarcioni, Matthias Titeux, Alain Hovnanian, Enno Schmidt, Stephanie Goletz
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
